References
- Halasi M, Gartel AL. FOX(M1) news–it is cancer. Mol Cancer Therap 2013 12:245-54; PMID:23443798; http://dx.doi.org/10.1158/1535-7163.MCT-12-0712
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
- Radhakrishnan SK, Bhat UG, Hughes DE, Wang IC, Costa RH, Gartel AL. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res 2006 66:9731-5; PMID:17018632; http://dx.doi.org/10.1158/0008-5472.CAN-06-1576
- Bhat UG, Halasi M, Gartel AL. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS One 2009 4:e5592; PMID:19440351; http://dx.doi.org/10.1371/journal.pone.0005592
- Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. PLoS One 2009 4:e6593; PMID:19672316; http://dx.doi.org/10.1371/journal.pone.0006593
- Halasi M, Gartel AL. A novel mode of FoxM1 regulation: positive auto-regulatory loop. Cell Cycle 2009 8:1966-7; PMID:19411834; http://dx.doi.org/10.4161/cc.8.12.8708
- Gartel AL. A new target for proteasome inhibitors: FoxM1. Expert Opin Investig Drugs 2010 19:235-42; PMID:20074015; http://dx.doi.org/10.1517/13543780903563364
- Gartel AL. Thiazole antibiotics siomycin a and thiostrepton inhibit the transcriptional activity of FOXM1. Front Oncol 2013 3:150; PMID:23761863; http://dx.doi.org/10.3389/fonc.2013.00150
- Gartel AL. Thiostrepton, proteasome inhibitors and FOXM1. Cell Cycle 2011 10:4341-2; PMID:22134246; http://dx.doi.org/10.4161/cc.10.24.18544
- Gartel AL. The oncogenic transcription factor FOXM1 and anticancer therapy. Cell Cycle 2012 11:3341-2; PMID:22918255; http://dx.doi.org/10.4161/cc.21841
- Cheng XH, Black M, Ustiyan V, Le T, Fulford L, Sridharan A, Medvedovic M, Kalinichenko VV, Whitsett JA, Kalin TV. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene. PLoS Genet 2014 10:e1004656; PMID:25254494; http://dx.doi.org/10.1371/journal.pgen.1004656
- Kalin TV, Wang IC, Ackerson TJ, Major ML, Detrisac CJ, Kalinichenko VV, Lyubimov A, Costa RH. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 2006 66:1712-20; PMID:16452231; http://dx.doi.org/10.1158/0008-5472.CAN-05-3138
- Mann MJ, Dzau VJ. Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Investig 2000 106:1071-5; PMID:11067859; http://dx.doi.org/10.1172/JCI11459